Research ArticleCancer

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells

See allHide authors and affiliations

Science Translational Medicine  07 Sep 2016:
Vol. 8, Issue 355, pp. 355ra117
DOI: 10.1126/scitranslmed.aag1180
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article